{
    "2021-06-15": [
        [
            {
                "time": "",
                "original_text": "风投女王徐新和市值400亿的益丰大药房！",
                "features": {
                    "keywords": [
                        "风投",
                        "徐新",
                        "益丰大药房",
                        "市值"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "广发基金刘玉：“风险控制是我管理基金时绷着的一根弦”",
                "features": {
                    "keywords": [
                        "广发基金",
                        "刘玉",
                        "风险控制"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "西南证券---医药行业周报：结合业绩和估值节后逢低布局【行业研究】",
                "features": {
                    "keywords": [
                        "西南证券",
                        "医药行业",
                        "周报",
                        "业绩",
                        "估值",
                        "逢低布局"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "医药行业2021年6月投资月报：6月仍然是较好的窗口期 两条思路配置医药",
                "features": {
                    "keywords": [
                        "医药行业",
                        "2021年6月",
                        "投资月报",
                        "窗口期",
                        "配置思路"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}